Enhanced CD27 expression on immune cells such as CD8+ and CD4+ T cells residing in the tumor microenvironment, FoxP3-expressing CD4+ T, and CD3−NK1.1+ natural killer (NK) cells augments the activities of these cells [51]. The gene discussed is CD8A; the disease is neoplasm.